Structures by: Pujol-Giménez J.
Total: 3
6-methyl-2-(3-methyl-4,5,6,7-tetrahydro-2H-indazol-2-yl)pyrimidin-4(3H)-one
C13H16N4O
RSC Medicinal Chemistry (2020)
a=8.1640(3)Å b=8.5511(4)Å c=19.8770(7)Å
α=93.396(3)° β=99.154(3)° γ=117.195(4)°
2-(3-ethyl-4,5,6,7-tetrahydro-2H-indazol-2-yl)-6-methylpyrimidin-4(3H)-one
C14H18N4O
RSC Medicinal Chemistry (2020)
a=18.8002(2)Å b=9.62410(10)Å c=14.3730(2)Å
α=90° β=90° γ=90°
6-ethyl-4-hydroxy-2-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)pyrimidin-1-ium
Cl,C10H13N4O2,H2O
RSC Medicinal Chemistry (2020)
a=8.66205(5)Å b=14.39226(6)Å c=9.94738(4)Å
α=90° β=90.8062(4)° γ=90°